Remove Dementia Remove Quality of Life Remove Research
article thumbnail

Heart–brain interaction in cardiogenic dementia: pathophysiology and therapeutic potential

Frontiers in Cardiovascular Medicine

Cardiogenic dementia is a cognitive impairment caused by heart dysfunction and has received increasing research attention. The prevention and treatment of cardiogenic dementia are essential to improve the quality of life, particularly in the elderly and aging population.

article thumbnail

Why Exercise Is The Key To A Longer Life

Dr. Paddy Barrett

While I have covered many of these fitness measures individually in previous posts, I wanted to summarise these metrics and how they relate to living longer and preventing major diseases such as cardiovascular disease, cancer and dementia. Fitness & Dementia This relationship is also clearly evident when it comes to rates of dementia.

Exercise 116
article thumbnail

National A-Fib Numbers Higher Than Previously Thought

DAIC

11, 2024 — In the first national estimate in two decades, researchers at the University of California-San Francisco (UCSF) report that 10.5 The data were standardized to reflect the entire country, and researchers estimated the current national prevalence to be at least 10.55 tim.hodson Wed, 09/11/2024 - 15:40 Sept. million U.S.

article thumbnail

Have We Turned The Tide On Obesity?

Dr. Paddy Barrett

Dementia is a leading cause of death and a major concern for most people as they age. Optimal metabolic health is linked to reduced rates of dementia, but the question again is whether the use of medications such as Ozempic might also delay the onset of dementia. Pharmaceutical Research, Vol. N Engl J Med. 2024 Jun 21.

Obesity 81
article thumbnail

Abstract TP123: Physician perspectives on acute evaluation and determining goals of stroke care for people living with dementia or disability: Results from the SEED mixed-methods study

Stroke Journal

Background:Around one in three strokes are experienced by people living with disability or dementia (PLWD), yet there is currently no consensus to guide physicians in evaluating baseline status in this patient population and determining goals of care. Stroke, Volume 56, Issue Suppl_1 , Page ATP123-ATP123, February 1, 2025.

article thumbnail

The Data For Weight Loss Medications Just Keeps Pouring In.

Dr. Paddy Barrett

Recent research suggested that the weight loss market was estimated to be worth $224 billion annually in 2021 and is estimated to exceed $400 billion by 2024 1. Although not generally considered a condition that can kill you, it can certainly impact your quality of life and limit the activities you do on a daily basis.

Obesity 79
article thumbnail

Long-Term Cognitive Decline After Subarachnoid Hemorrhage: Pathophysiology, Management, and Future Directions

Stroke Journal

Subarachnoid hemorrhage is a critical neurological condition accounting for about 5% of all strokes, and survivors experience long-term cognitive deterioration and increased risk of dementia. These have emerging treatments that offer promise for the mitigation of effects such as inflammation, iron chelation, and microvascular dysfunction.